Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Comparison of an Ultra-low Strut Thickness Everolimus-eluting Biodegradable Polymer Stent Versus Durable Polymer Everolimus-eluting Stents in Patients Treated with Percutaneous Coronary Intervention in an All Comer Population (The SORT OUT XII Trial)

NCT06692140 is registered in ClinicalTrials.gov with Odense University Hospital as lead sponsor.

NCT NCT06692140
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06692140 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Comparison of an Ultra-low Strut Thickness Everolimus-eluting Biodegradable Polymer Stent Versus Durable Polymer Everolimus-eluting Stents in Patients Treated with Percutaneous Coronary Intervention in an All Comer Population (The SORT OUT XII Trial)
Lead sponsor
Odense University Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
November 16, 2024
Completion date
July 1, 2032
Enrollment
3,150 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, ischemia, myocardial, percutaneous coronary intervention (pci)